July 29, 2025

Adaptive Biotechnologies (ADPT) Stock Analysis: A Promising Biotech Play with 14.45% Upside Potential

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a key player in the biotechnology sector, is attracting attention from investors with its innovative approach to diagnosing and treating diseases..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: Exploring a Potential Upside of 143.95% in the Biotech Arena

Apogee Therapeutics, Inc. (NASDAQ: APGE), a burgeoning entity in the biotechnology sector, has caught the attention of investors with its promising prospects in the treatment of..

Omnicell, Inc. (OMCL) Stock Analysis: A 51% Upside Potential in Healthcare Tech

Omnicell, Inc. (NASDAQ: OMCL) stands as a noteworthy player in the healthcare technology sector, specializing in medication management solutions and adherence tools. With a market capitalization..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 39.68% Potential Upside

Investors with a focus on the healthcare sector may find Pacira BioSciences, Inc. (NASDAQ: PCRX) an intriguing prospect given its potential upside of nearly 40%. With..

HUTCHMED (China) Limited (HCM) Stock Analysis: Discovering a 35% Upside Potential in the Healthcare Sector

HUTCHMED (China) Limited (HCM), a prominent player in the healthcare sector, is capturing investor attention with its promising 35.03% potential upside, according to current analyst targets...

UFP Technologies (UFPT) Stock Analysis: 27% Potential Upside in the Medical Device Sector

UFP Technologies, Inc. (NASDAQ: UFPT) stands out as a compelling player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of..

Neogen Corporation (NEOG) Stock Analysis: Exploring a 38% Potential Upside in the Healthcare Sector

Neogen Corporation (NASDAQ: NEOG) stands at the intersection of innovation and essential services in the healthcare sector. As a key player in the diagnostics and research..

CG Oncology, Inc. (CGON) Growth Potential: Exploring a 119.64% Upside Amidst Clinical Trials Success

CG Oncology, Inc. (CGON) is a biopharmaceutical company that has garnered significant attention in the healthcare sector, particularly in the biotechnology industry. Headquartered in Irvine, California,..

PACS Group, Inc. (PACS) Stock Analysis: Exploring a 159% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, PACS Group, Inc. (PACS) presents an intriguing proposition. Operating in the niche of skilled nursing and assisted living..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Exploring the 22.37% Potential Upside for Investors

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), a key player in the healthcare sector, is capturing the attention of investors with its significant growth potential. With a market..

Azenta, Inc. (AZTA) Stock Analysis: Navigating Growth in the Healthcare Sector

Azenta, Inc. (NASDAQ: AZTA), an influential player in the healthcare sector, specializes in providing cutting-edge biological and chemical compound sample exploration and management solutions. With its..

Twist Bioscience Corporation (TWST) Stock Analysis: Unlocking a 32% Potential Upside in Synthetic DNA Innovation

Twist Bioscience Corporation (NASDAQ: TWST) is making waves in the healthcare sector with its innovative approach to synthetic DNA products. Headquartered in South San Francisco, California,..

Merus N.V. (MRUS) Stock Analysis: Exploring a 37% Upside in the Biotech Sector

The Netherlands-based Merus N.V. (NASDAQ: MRUS) is making waves in the biotechnology sector with its innovative approach to developing antibody therapeutics. As a clinical-stage immuno-oncology company,..

MannKind Corporation (MNKD): Analyst Ratings Highlight a Promising 130% Upside

MannKind Corporation (NASDAQ: MNKD), a notable player in the biotechnology sector, is capturing investor attention with its promising growth prospects and analyst ratings that suggest a..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Uncovering a Potential 314.93% Upside in the Biotech Sector

For investors seeking opportunities in the biotechnology sector, Structure Therapeutics Inc. (NASDAQ: GPCR) presents a compelling case with a notable potential upside of 314.93%, based on..

Amneal Pharmaceuticals, Inc. (AMRX): Investor Outlook with a 43.82% Potential Upside

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX), a prominent player in the healthcare sector, is capturing the attention of investors with its promising growth potential. As a key..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: A Potential 87% Upside in the Precision Medicine Space

Investors with an eye for innovation in the healthcare sector should closely monitor IDEAYA Biosciences, Inc. (NASDAQ: IDYA). The precision medicine oncology company, with a market..

Beam Therapeutics Inc. (BEAM): Analyst Ratings Reveal 111% Potential Upside for Biotech Innovator

Beam Therapeutics Inc. (NASDAQ: BEAM), a pioneer in the field of precision genetic medicines, stands at the forefront of the biotechnology industry with its innovative approaches..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Evaluating a 27.97% Upside Potential

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a leading biopharmaceutical company specializing in the development of treatments for central nervous system (CNS) disorders and rare diseases, presents an..

Envista Holdings Corporation (NVST) Stock Analysis: Navigating Opportunities in the Dental Market

Envista Holdings Corporation (NYSE: NVST) stands as a significant player in the healthcare sector, specifically within the Medical Instruments & Supplies industry. With a market capitalization..

Search

Funds

July 29, 2025

Search

Funds

July 29, 2025

FTSE 100

Funds